Back

Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKC/Gal-3 signaling pathway attenuates adverse cardiac fibrosis, following myocardial infarction

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Molecular mechanisms of cardiac disease Heart Failure ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Domingo Pascual Figal

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)

9 More presentations in this session

Presentation thumbnail
Direct monitoring of cAMP at cardiac ryanodine receptor reveals altered beta2-adrenoceptor dependent regulation in hypertrophy
Doctor F. Berisha (Hamburg, DE)
Abstract
Presentation thumbnail
Gene-gene interaction in ischemic cardiopathy by MDR: beyond logistic regression
Professor A. Pereira (Funchal, PT)
Abstract
Presentation thumbnail
Specific invalidation of AMP-activated protein kinase alpha1 in cardiac fibroblasts exacerbates left ventricular remodeling following ischemia in mice
Doctor E. Daskalopoulos (Brussels, BE)
Abstract
Presentation thumbnail
Yin-Yang 1 transcription factor modulates sST2 on adverse cardiac remodeling post-myocardial infarction
Professor D. Pascual Figal (Murcia, ES)
Abstract
Presentation thumbnail
Sphingosine-1-phosphate receptor 2 agonist mobilizes endogenous muse cells from bone marrow via S1P-S1PR2 axis for cardiac tissue repair after acute myocardial infarction
Doctor S. Minatoguchi (Gifu, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Molecular mechanisms of cardiac disease

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
European Heart Journal
thumbnail
Congress Presentation
ESC Textbook of Heart Failure
thumbnail
Congress Session
Heart Failure 2025 highlights

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources